Kura Oncology Inc at Clinical Update Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by, and welcome to Kura Oncology Clinical Update Conference call and Webcast. (Operator Instructions)
I would now like to hand the conference over to your speaker host today, Pete De Spain, Vice President of Investor Relations.
Thank you, Olivia. Good morning, and welcome to Kura Oncology's KO-539 Clinical Update Conference Call. I'm joined on the call by Dr. Troy Wilson, our President and CEO; Dr. Marc Grasso, our CFO and CBO, is also with us and available to answer questions.
Before I turn the call over to Dr. Wilson, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to Kura's filings with the SEC, which are available from the SEC or on the Kura Oncology
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |